Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Belo, Luís ^a,b   Nascimento, Henrique ^a,b   Kohlova, Michaela ^c   Bronze da Rocha, Elsa ^a,b   Fernandes, João ^a,c   Costa, Elísio ^a,b   Catarino, Cristina ^a,b   Aires, Luísa ^a,d   Mansilha, Helena Ferreira ^e   Rocha Pereira, Petronila ^f   Quintanilha, Alexandre ^a,b   Rêgo, Carla ^a   Santos Silva, Alice ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY INSTITUTE OF MAIA   (Portugal)

^e Centro Hospitalar Universitario do Porto   (Portugal)

^f UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; GLUCURONOSYLTRANSFERASE 1A1; HEMOGLOBIN; INSULIN; GLUCURONOSYLTRANSFERASE; UGT1A1 ENZYME;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CELL VOLUME; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE COUNT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GROUPS BY AGE; HEMATOCRIT; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; UGT1A1 GENE; ADOLESCENT; ALLELE; BLOOD; CASE CONTROL STUDY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PRESCHOOL CHILD;

ADIPOSITY; ADOLESCENT; ALLELES; BILIRUBIN; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; OBESITY; POLYMORPHISM, GENETIC;

EID: 84902491282     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098467     Document Type: Article

References (49)

1. Fevery J (2008) Bilirubin in clinical practice: a review. Liver Int 28: 592-605.
2. Gong QH, Cho JW, Huang T, Potter C, Gholami N, et al. (2001) Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11: 357-368. (Pubitemid 32537410)
3. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, et al. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333: 1171-1175.
4. Beutler E, Gelbart T, Demina A (1998) Racial variability in the UDPglucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A 95: 8170-8174. (Pubitemid 28326085)
5. Kaniwa N, Kurose K, Jinno H, Tanaka-Kagawa T, Saito Y, et al. (2005) Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C. T (P229L) found in an African- American. Drug Metab Dispos 33: 458-465. (Pubitemid 40279948)
6. Clementi M, Di Gianantonio E, Fabris L, Forabosco P, Strazzabosco M, et al. (2007) Inheritance of hyperbilirubinemia: evidence for a major autosomal recessive gene. Dig Liver Dis 39: 351-355. (Pubitemid 46432246)
7. Tiribelli C, Ostrow JD (2005) The molecular basis of bilirubin encephalopathy and toxicity: report of an EASL Single Topic Conference, Trieste, Italy, 1-2 October, 2004. J Hepatol 43: 156-166. (Pubitemid 40805287)
8. Gourley GR (1997) Bilirubin metabolism and kernicterus. Adv Pediatr 44: 173- 229.
9. Wu TW, Fung KP, Wu J, Yang CC, Weisel RD (1996) Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51: 859-862. (Pubitemid 26096296)
10. Weinberger B, Archer FE, Kathiravan S, Hirsch DS, Kleinfeld AM, et al. (2013) Effects of bilirubin on neutrophil responses in newborn infants. Neonatology 103: 105-111.
11. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, et al. (2006) Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 114: 1476-1481. (Pubitemid 44527002)
12. Novotny L, Vitek L (2003) Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 228: 568-571. (Pubitemid 37203679)
13. Horsfall LJ, Nazareth I, Petersen I (2012) Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 126: 2556- 2564.
14. Temme EH, Zhang J, Schouten EG, Kesteloot H (2001) Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 12: 887- 894.
15. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, et al. (2012) Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 126: 598-603.
16. Nascimento H, Costa E, Rocha-Pereira P, Rego C, Mansilha HF, et al. (2012) Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochem J 6: 43-50.
17. Padez C, Fernandes T, Mourao I, Moreira P, Rosado V (2004) Prevalence of overweight and obesity in 7-9-year-old Portuguese children: trends in body mass index from 1970-2002. Am J Hum Biol 16: 670-678. (Pubitemid 39517314)
18. Alexander CM, Landsman PB, Grundy SM (2008) The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 10: 246-250. (Pubitemid 351247341)
19. Hwang HJ, Kim SH (2010) Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults. Clin Chim Acta 411: 1496-1501.
20. Jo J, Yun JE, Lee H, Kimm H, Jee SH (2011) Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population. Endocrine 39: 182-189.
21. Wu Y, Li M, Xu M, Bi Y, Li X, et al. (2011) Low serum total bilirubin concentrations are associated with increased prevalence of metabolic syndrome in Chinese. J Diabetes 3: 217-224.
22. Lin LY, Kuo HK, Hwang JJ, Lai LP, Chiang FT, et al. (2009) Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 203: 563-568.
23. Devries MC, Samjoo IA, Hamadeh MJ, Tarnopolsky MA (2008) Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women. Obesity (Silver Spring) 16: 2281-2288.
24. Jenko-Praznikar Z, Petelin A, Jurdana M, Ziberna L (2013) Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: an early indicator of metabolic syndrome? Metabolism 62: 976-985.
25. Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235.
26. Gaffney D, Campbell RA (1994) A PCR based method to determine the Kalow allele of the cholinesterase gene: the E1k allele frequency and its significance in the normal population. J Med Genet 31: 248-250.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412- 419.
28. Rocha S, Costa E, Ferreira F, Cleto E, Barbot J, et al. (2010) Hereditary spherocytosis and the (TA)nTAA polymorphism of UGT1A1 gene promoter region-a comparison of the bilirubin plasmatic levels in the different clinical forms. Blood Cells Mol Dis 44: 117-119.
29. Karatzas A, Giannatou E, Tzortzis V, Gravas S, Aravantinos E, et al. (2010) Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men. Cancer Epidemiol 34: 345- 349.
30. Ostanek B, Furlan D, Mavec T, Lukac-Bajalo J (2007) UGT1A1(TA)n promoter polymorphism-a new case of a (TA)8 allele in Caucasians. Blood Cells Mol Dis 38: 78-82. (Pubitemid 46186058)
31. Rodrigues C, Vieira E, Santos R, de Carvalho J, Santos-Silva A, et al. (2012) Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects. Blood Cells Mol Dis 48: 166-172.
32. Yip R, Johnson C, Dallman PR (1984) Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency. Am J Clin Nutr 39: 427- 436.
33. Chauhan A, Grissom M (2013) Disorders of childhood growth and development: precocious puberty. FP Essent 410: 25-31.
34. Wonisch W, Falk A, Sundl I, Winklhofer-Roob BM, Lindschinger M (2012) Oxidative stress increases continuously with BMI and age with unfavourable profiles in males. Aging Male 15: 159-165.
35. Andersson C, Weeke P, Fosbol EL, Brendorp B, Kober L, et al. (2009) Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metabolism 58: 1109-1115.
36. Coimbra S, Catarino C, Santos-Silva A (2013). The role of adipocytes in the modulation of iron metabolism in obesity. Obes Rev 14: 771-779.
37. Taube A, Schlich R, Sell H, Eckardt K, Eckel J (2012) Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 302: H2148-2165.
38. Greco EA, Francomano D, Fornari R, Marocco C, Lubrano C, et al. (2013) Negative association between trunk fat, insulin resistance and skeleton in obese women. World J Diabetes 4: 31-39.
39. Bondia-Pons I, Ryan L, Martinez JA (2012) Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 68: 701-711.
40. D'nArchivio M, Annuzzi G, Vari R, Filesi C, Giacco R, et al. (2012) Predominant role of obesity/insulin resistance in oxidative stress development. Eur J Clin Invest 42: 70-78.
41. Hwang HJ, Lee SW, Kim SH (2011) Relationship between bilirubin and Creactive protein. Clin Chem Lab Med 49: 1823-1828.
42. Ohnaka K, Kono S, Inoguchi T, Yin G, Morita M, et al. (2010) Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Clin Pract 88: 103-110.
43. Yoshino S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, et al. (2011) Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. J Atheroscler Thromb 18: 403- 412.
44. Yu K, Kim C, Sung E, Shin H, Lee H (2011) Association of Serum Total Bilirubin with Serum High Sensitivity C-reactive Protein in Middle-aged Men. Korean J Fam Med 32: 327-333.
45. Abraham NG, Tsenovoy PL, McClung J, Drummond GS (2008) Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des 14: 412- 421.
46. Bruce CR, Carey AL, Hawley JA, Febbraio MA (2003) Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52: 2338-2345. (Pubitemid 37059505)
47. Chang CL, Au LC, Huang SW, Fai Kwok C, Ho LT, et al. (2011) Insulin upregulates heme oxygenase-1 expression in 3T3-L1 adipocytes via PI3-kinaseand PKC-dependent pathways and heme oxygenase-1-associated microRNA downregulation. Endocrinology 152: 384-393.
48. Nascimento H, Silva L, Lourenco P, Weinfurterova R, Castro E, et al. (2009) Lipid profile in Portuguese obese children and adolescents: interaction of apolipoprotein E polymorphism with adiponectin levels. Arch Pediatr Adolesc Med 163: 1030-1036.
49. Swift DL, Johannsen NM, Earnest CP, Blair SN, Church TS (2012) Effect of different doses of aerobic exercise training on total bilirubin levels. Med Sci Sports Exerc 44: 569-574.